UPDATE : Wednesday, September 18, 2019
상단여백
China OKs Huonland's hyaluronic acid eye drop
Huonland, a joint venture between Huons and Beijing Northland, said that it...
by Lee Han-soo  |  2019-07-15 13:57
라인
Japanese pharma companies closely following 'Boycott Japan' campaign
Japan is moving to remove Korea from the white list of importers of its hi-...
by Lee Han-soo  |  2019-07-12 17:07
라인
Daewoong to co-promote Lundbeck Korea's Alzheimer's disease treatment
Daewoong Pharmaceutical said that it has agreed to promote Lundbeck Korea’s...
by Lee Han-soo  |  2019-07-12 15:13
라인
Regulator OKs Merck Korea's relapsing-remitting multiple sclerosis treatment
Merck Biopharma Korea said that the Ministry of Food and Drug Safety has gr...
by Lee Han-soo  |  2019-07-11 17:39
라인
Humira permitted for nursing, pregnant patients
The local regulator allowed nursing and pregnant patients to use autoimmune...
by Kim Yun-mi  |  2019-07-11 16:41
라인
SCM Life Science, MitoImmune Therapeutics to develop new treatment
SCM Life Science said that it has agreed with MitoImmune Therapeutics to de...
by Lee Han-soo  |  2019-07-11 16:40
라인
Acute renal failure reported in ibandronate injections
The government warned that ibandronate injections for the treatment of oste...
by Lee Hye-seon  |  2019-07-11 13:34
라인
Yuyu holds 3rd annual compliance program workshop
Yuyu Pharmaceutical said that it has finished its third annual “Self-Compli...
by Lee Han-soo  |  2019-07-11 12:09
라인
Contera Pharma gets ₩3 billion funding from venture capital
Contera Pharma, a Copenhagen-based subsidiary of Korean drugmaker Bukwang P...
by Jeong Sae-im  |  2019-07-10 17:28
라인
Court to test Nabota’s spore-forming to end Daewoong-Medytoxin dispute
The Seoul Central District Court has begun to test whether Nabota, botulinu...
by Jeong Sae-im  |  2019-07-10 12:44
라인
'Teva's Fremanezumab improves migraine-related disorders, quality of life'
Teva-Handok said that it has presented the exploratory endpoint results of ...
by Lee Han-soo  |  2019-07-09 16:57
라인
ISU Abxis, Kyungpook National University to co-develop Alzheimer's disease treatment
ISU Abxis said it has signed an agreement to co-develop an Alzheimer's ...
by Lee Han-soo  |  2019-07-09 16:06
라인
Sanofi Aventis names new general manager for consumer healthcare
Sanofi Aventis said that it has appointed Fabien Schmitt as the general man...
by Lee Han-soo  |  2019-07-09 15:16
라인
GSK's Alitoc becoming salvation treatment for chronic hand eczema patients
GSK Korea said Tuesday a fast and accurate treatment is needed to cure chro...
by Lee Han-soo  |  2019-07-09 14:44
라인
Pfizer fails to cut participants in Xeljanz’ post-marketing surveillance
Pfizer Korea has failed to reduce the number of target participants in post...
by Lee Hye-seon  |  2019-07-08 16:39
라인
Eutilex wins patent for immunotherapy in Australia
Eutilex said that it has patented EU101, an immunotherapy targeting 4-1BB, ...
by Lee Han-soo  |  2019-07-08 14:27
라인
Yuhan invests ₩6 billion in Imnewrun Biosciences
Yuhan Corp. said it has invested 6 billion won ($5.09 million) in Imnewrun ...
by Lee Han-soo  |  2019-07-08 12:05
라인
Dong-A ST, Dongwha Pharm lose status of innovative drugmaker
Dong-A ST and Dongwha Pharm failed to renew the state-designated certificat...
by Jeong Sae-im  |  2019-07-05 16:00
라인
Lilly aims to reshape Korea’s breast cancer treatment market
Lilly Korea is seeking to reshape Korea’s breast cancer treatment market on...
by Lee Han-soo  |  2019-07-05 16:00
라인
‘Truvada will improve Korea's HIV treatment environment’
Gilead Science is strengthening its position in the local human immunodefic...
by Lee Han-soo  |  2019-07-04 10:53
여백
여백
여백
Back to Top